GLS2 and cancer: A high percentage of cell death was observed in early apoptotic and late apoptotic human carcinoma cells (HCT 116) more than adenocarcinoma cells (LS 174T) after treatment with L-glutaminase, while the necrotic pathway death in both cancer cells appeared in a similar percentage (Figure 11).